Latest Insider Transactions at Ingevity Corp (NGVT)
This section provides a real-time view of insider transactions for Ingevity Corp (NGVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ingevity Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ingevity Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2023
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,144
-9.05%
|
$93,808
$82.87 P/Share
|
|
Jan 04
2023
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
317
+12.49%
|
$22,507
$71.02 P/Share
|
|
Dec 02
2022
|
Erik Spencer Ripple Chief Growth and Innovation Of |
SELL
Open market or private sale
|
Direct |
856
-7.81%
|
$65,912
$77.84 P/Share
|
|
Dec 01
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Open market or private sale
|
Direct |
1,639
-29.09%
|
$126,203
$77.97 P/Share
|
|
Dec 01
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
BUY
Exercise of conversion of derivative security
|
Direct |
1,639
+22.54%
|
$73,755
$45.04 P/Share
|
|
Nov 01
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-8.27%
|
$24,120
$67.97 P/Share
|
|
Oct 03
2022
|
Karen G Narwold |
BUY
Grant, award, or other acquisition
|
Direct |
362
+4.09%
|
$22,444
$62.2 P/Share
|
|
Oct 03
2022
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
362
+15.98%
|
$22,444
$62.2 P/Share
|
|
Sep 06
2022
|
Phillip John Platt SVP, Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-6.42%
|
$28,314
$66.17 P/Share
|
|
Sep 06
2022
|
Erik Spencer Ripple Chief Growth and Innovation Of |
SELL
Payment of exercise price or tax liability
|
Direct |
511
-4.45%
|
$33,726
$66.17 P/Share
|
|
Jul 26
2022
|
Benjamin G. Wright |
BUY
Grant, award, or other acquisition
|
Direct |
1,542
+50.0%
|
-
|
|
Jul 26
2022
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,542
+50.0%
|
-
|
|
Jul 01
2022
|
Karen G Narwold |
BUY
Grant, award, or other acquisition
|
Direct |
355
+4.18%
|
$22,365
$63.47 P/Share
|
|
Jun 27
2022
|
Christine Stunyo SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,334
+50.0%
|
-
|
|
Apr 28
2022
|
Jean S Blackwell |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+36.48%
|
-
|
|
Apr 28
2022
|
Luis M Fernandez Moreno Interim President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+9.78%
|
-
|
|
Apr 28
2022
|
J Michael Fitzpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+13.12%
|
-
|
|
Apr 28
2022
|
Diane H. Gulyas |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+30.71%
|
-
|
|
Apr 28
2022
|
Frederick J Lynch |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+9.81%
|
-
|
|
Apr 28
2022
|
Karen G Narwold |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+19.98%
|
-
|
|
Apr 28
2022
|
Daniel F Sansone |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+18.82%
|
-
|
|
Apr 19
2022
|
Mary Dean Hall EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,339
-7.7%
|
$213,696
$64.22 P/Share
|
|
Apr 01
2022
|
Karen G Narwold |
BUY
Grant, award, or other acquisition
|
Direct |
347
+5.61%
|
$22,208
$64.91 P/Share
|
|
Feb 28
2022
|
Mary Dean Hall EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+12.06%
|
-
|
|
Feb 28
2022
|
Steven Paul Hulme SVP and Pres, APT |
BUY
Grant, award, or other acquisition
|
Direct |
599
+50.0%
|
-
|
|
Feb 28
2022
|
John C. Fortson President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,333
+12.55%
|
-
|
|
Feb 28
2022
|
John C. Fortson President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,126
-2.12%
|
$280,568
$68.23 P/Share
|
|
Feb 28
2022
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,438
+16.24%
|
-
|
|
Feb 28
2022
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
BUY
Grant, award, or other acquisition
|
Direct |
2,073
+7.31%
|
-
|
|
Feb 28
2022
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
SELL
Payment of exercise price or tax liability
|
Direct |
555
-1.13%
|
$37,740
$68.23 P/Share
|
|
Feb 28
2022
|
Michael P. Smith EVP, President Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
469
-1.06%
|
$31,892
$68.23 P/Share
|
|
Feb 28
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
BUY
Grant, award, or other acquisition
|
Direct |
1,393
+24.23%
|
-
|
|
Feb 28
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-3.46%
|
$7,208
$68.23 P/Share
|
|
Feb 28
2022
|
Phillip John Platt SVP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
733
+9.89%
|
-
|
|
Feb 28
2022
|
Phillip John Platt SVP, Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
140
-1.16%
|
$9,520
$68.23 P/Share
|
|
Feb 26
2022
|
John C. Fortson President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-2.04%
|
$93,228
$68.23 P/Share
|
|
Feb 26
2022
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
208
-2.47%
|
$14,144
$68.23 P/Share
|
|
Feb 26
2022
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
SELL
Payment of exercise price or tax liability
|
Direct |
305
-1.22%
|
$20,740
$68.23 P/Share
|
|
Feb 26
2022
|
Michael P. Smith EVP, President Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
261
-1.16%
|
$17,748
$68.23 P/Share
|
|
Feb 26
2022
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
77
-2.45%
|
$5,236
$68.23 P/Share
|
|
Feb 26
2022
|
Phillip John Platt SVP, Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
66
-1.07%
|
$4,488
$68.23 P/Share
|
|
Feb 01
2022
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
870
-9.41%
|
$57,420
$66.49 P/Share
|
|
Jan 03
2022
|
Karen G Narwold |
BUY
Grant, award, or other acquisition
|
Direct |
301
+5.2%
|
$22,274
$74.85 P/Share
|
|
Nov 08
2021
|
Michael P. Smith EVP, President Perf Chemicals |
SELL
Open market or private sale
|
Direct |
7,878
-13.93%
|
$630,240
$80.81 P/Share
|
|
Nov 08
2021
|
Michael P. Smith EVP, President Perf Chemicals |
BUY
Exercise of conversion of derivative security
|
Direct |
7,878
+12.18%
|
$338,754
$43.65 P/Share
|
|
May 07
2021
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
SELL
Open market or private sale
|
Direct |
5,178
-16.97%
|
$440,130
$85.76 P/Share
|
|
May 07
2021
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
BUY
Exercise of conversion of derivative security
|
Direct |
5,178
+14.51%
|
$139,806
$27.38 P/Share
|
|
Apr 23
2021
|
Jean S Blackwell |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+15.88%
|
-
|
|
Apr 23
2021
|
Luis M Fernandez Moreno Interim President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+8.27%
|
-
|
|
Apr 23
2021
|
J Michael Fitzpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+11.66%
|
-
|